JP2017533915A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017533915A5 JP2017533915A5 JP2017523330A JP2017523330A JP2017533915A5 JP 2017533915 A5 JP2017533915 A5 JP 2017533915A5 JP 2017523330 A JP2017523330 A JP 2017523330A JP 2017523330 A JP2017523330 A JP 2017523330A JP 2017533915 A5 JP2017533915 A5 JP 2017533915A5
- Authority
- JP
- Japan
- Prior art keywords
- ibs
- patients
- hmo
- bacterial overgrowth
- mucosal barrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021103785A JP7301093B2 (ja) | 2014-10-29 | 2021-06-23 | 過敏性腸症候群の治療のための合成組成物および方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201470663 | 2014-10-29 | ||
| DKPA201470663 | 2014-10-29 | ||
| PCT/DK2015/050332 WO2016066175A1 (en) | 2014-10-29 | 2015-10-29 | Synthetic composition and method for treating irritable bowel syndrome |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021103785A Division JP7301093B2 (ja) | 2014-10-29 | 2021-06-23 | 過敏性腸症候群の治療のための合成組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017533915A JP2017533915A (ja) | 2017-11-16 |
| JP2017533915A5 true JP2017533915A5 (cg-RX-API-DMAC7.html) | 2018-11-08 |
| JP7182872B2 JP7182872B2 (ja) | 2022-12-05 |
Family
ID=55856643
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017523330A Expired - Fee Related JP7182872B2 (ja) | 2014-10-29 | 2015-10-29 | 過敏性腸症候群の治療のための合成組成物および方法 |
| JP2021103785A Active JP7301093B2 (ja) | 2014-10-29 | 2021-06-23 | 過敏性腸症候群の治療のための合成組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021103785A Active JP7301093B2 (ja) | 2014-10-29 | 2021-06-23 | 過敏性腸症候群の治療のための合成組成物および方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US20160346303A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3212197A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7182872B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN115364113A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016066175A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107108677B (zh) * | 2014-10-24 | 2020-08-07 | 格礼卡姆股份公司 | Hmo的混合物 |
| US20160346303A1 (en) | 2014-10-29 | 2016-12-01 | Glycom A/S | Synthetic composition and method for treating irritable bowel syndrome |
| US11040050B2 (en) | 2014-10-29 | 2021-06-22 | Glycom A/S | Composition comprising HMSs/HMOs and use thereof |
| US11040049B2 (en) | 2014-10-29 | 2021-06-22 | Glycom A/S | Composition comprising HMSs/HMOs and use thereof |
| PT3264922T (pt) * | 2015-03-05 | 2025-01-07 | Nestle Sa | Composições para utilização na melhoria da consistência ou frequência das fezes em lactentes ou crianças pequenas |
| ES2886951T3 (es) | 2015-09-14 | 2021-12-21 | Glycom As | Composición para su uso en la modulación de la microbiota |
| WO2017071715A1 (en) | 2015-10-28 | 2017-05-04 | Glycom A/S | Synthetic composition and method for modulating brain function and behaviour |
| US10780103B2 (en) | 2015-10-28 | 2020-09-22 | Glycom A/S | Synthetic composition and method for modulating emotion and mood disorders |
| US10857168B2 (en) | 2016-02-24 | 2020-12-08 | Glycom A/S | Synthetic composition for microbiota modulation |
| ES2938355T3 (es) * | 2016-05-05 | 2023-04-10 | Glycom As | Composición que comprende HMOS para el tratamiento de la diarrea no infecciosa |
| WO2017190755A1 (en) | 2016-05-05 | 2017-11-09 | Glycom A/S | Composition comprising hmos for use in the treatment of mast cell mediated visceral hypersensitivity and/or pain |
| US11224605B2 (en) | 2016-05-19 | 2022-01-18 | Glycom A/S | Synthetic composition |
| MX2018015187A (es) * | 2016-08-04 | 2019-04-24 | Nestec Sa | Composiciones nutricionales con 2fl y lnnt para su uso en la prevencion y/o tratamiento de la diarrea no causada por rotavirus mediante la accion en la disbiosis de la microbiota intestinal. |
| KR102593408B1 (ko) * | 2016-09-19 | 2023-10-25 | 프롤랙타 바이오사이언스, 인코포레이티드 | 정제된 인간 모유 올리고당 조성물 |
| AU2016101768B4 (en) * | 2016-09-28 | 2017-02-02 | Grech, Brian James DR | Treatment for Irritable Bowel Syndrome |
| GB201617519D0 (en) * | 2016-10-14 | 2016-11-30 | Genetic Analysis As | A companion diagnostic method for use in the treatment of irritable bowel syndrome with dietary interventions or faecal microbiota transplant |
| CN106668034A (zh) * | 2017-01-13 | 2017-05-17 | 华中科技大学同济医学院附属协和医院 | L‑岩藻糖在治疗消化道病变的药品和保健品中应用 |
| EP3589139A4 (en) * | 2017-03-01 | 2020-12-23 | Glycom A/S | SYNTHETIC COMPOSITION FOR MICROBIOTE MODULATION |
| WO2019087140A1 (en) * | 2017-11-02 | 2019-05-09 | Glycom A/S | One or more hmos for reducing or preventing fatigue and/or improving focus or concentration |
| US11452736B2 (en) | 2017-11-30 | 2022-09-27 | Glycom A/S | Mixture of HMOs for treating wheat sensitivity |
| US11602545B2 (en) * | 2017-12-05 | 2023-03-14 | Glycom A/S | Human milk oligosaccharides for treating migraine |
| BR112020011242A2 (pt) * | 2017-12-08 | 2020-11-17 | Jennewein Biotechnologie Gmbh | mistura seca por pulverização de oligossacarídeos de leite humano |
| EP3743078A4 (en) * | 2017-12-22 | 2022-01-19 | Glycom A/S | COMPOSITION WITH HMOs TO PREVENT OR REDUCE NOCICEPTION |
| MX2020007197A (es) | 2017-12-22 | 2020-09-03 | Nestle Sa | Composiciones para usar en la reduccion de la nocicepcion en infantes y niños pequeños. |
| US11642359B2 (en) | 2018-07-12 | 2023-05-09 | N.V. Nutricia | Nutritional composition for improving intestinal barrier integrity, preparation of the composition and method of treatment |
| JP2022513524A (ja) * | 2018-12-19 | 2022-02-08 | グリコム・アクティーゼルスカブ | 低fodmap食を使用してヒトを治療するための組成物および方法 |
| US20220054515A1 (en) * | 2018-12-21 | 2022-02-24 | Glycom A/S | Composition and method for promoting intestinal barrier healing |
| US20220249526A1 (en) * | 2019-06-12 | 2022-08-11 | Glycom A/S | Human milk oligosaccharides and compositions thereof for use in preventing, managing or treating symptoms related to migraine |
| ES1240969Y (es) * | 2019-09-18 | 2020-07-30 | Jennewein Biotechnologie Gmbh | Composiciones de cereales que contienen oligosacaridos de la leche humana |
| WO2021094993A1 (en) * | 2019-11-14 | 2021-05-20 | Glycom A/S | Synthetic composition for balancing the bile acid profile in the intestine |
| CN114761023A (zh) * | 2019-11-27 | 2022-07-15 | 格礼卡姆股份公司 | Hmo混合物 |
| IT201900023016A1 (it) * | 2019-12-04 | 2021-06-04 | Alesco Srl | Formulazioni comprendenti un minerale e un polisaccaride, loro composizioni e loro uso nella supplementazione di detto minerale |
| BR112022008956A2 (pt) | 2019-12-06 | 2022-08-02 | Nestle Sa | Composições para uso na redução de dor e/ou percepção de dor em bebês e crianças pequenas |
| EP4076474A4 (en) * | 2019-12-06 | 2024-02-28 | Glycom A/S | COMPOSITION CONTAINING 2'-FL AND DFL FOR USE IN A PAIN RELIEF METHOD |
| CN114786501A (zh) * | 2019-12-11 | 2022-07-22 | 雀巢产品有限公司 | 用于减少婴儿和幼儿的伤害感觉和/或其他健康益处的组合物 |
| WO2022118269A1 (en) * | 2020-12-04 | 2022-06-09 | Glycom A/S | Human milk oligosaccharides for use in supporting maturation or improvement of sleeping patterns |
| US20240041949A1 (en) * | 2020-12-09 | 2024-02-08 | Meiji Co., Ltd. | Composition comprising bacterium of the genus acidipropionibacterium or processed product thereof |
| WO2022155126A1 (en) * | 2021-01-12 | 2022-07-21 | Intrinsic Medicine, Inc. | Methods and compositions for supporting human health during space travel |
| US11712445B2 (en) | 2021-04-30 | 2023-08-01 | Sourabh Kharait | Compositions and methods for improving gastrointestinal function in subjects with renal disease |
| US20260165955A1 (en) * | 2022-03-18 | 2026-06-18 | Meiji Co., Ltd. | Composition for controlling growth of bacteria of the genus collinsella and use thereof |
| JPWO2024019141A1 (cg-RX-API-DMAC7.html) * | 2022-07-21 | 2024-01-25 | ||
| WO2025196272A1 (en) * | 2024-03-22 | 2025-09-25 | Dsm Ip Assets B.V. | Combination of mixtures of hmos with mfgm and their use |
| CN120570904A (zh) * | 2025-07-14 | 2025-09-02 | 苏州一兮生物技术有限公司 | 一种用于预防和/或治疗腹泻的组合物及其用途 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663321A (en) | 1984-06-26 | 1987-05-05 | Merck & Co., Inc. | Triazolobenzodiazepines and pharmaceutical use |
| FR2796082B1 (fr) | 1999-07-07 | 2003-06-27 | Centre Nat Rech Scient | Procede de production d'oligosaccharides |
| WO2004026257A2 (en) | 2002-09-20 | 2004-04-01 | The Board Of Regents Of The University Of Texas System | Treatment of irritable bowel syndrome and related bowel diseases |
| GB0312365D0 (en) | 2003-05-30 | 2003-07-02 | Univ Aston | Novel 3-substituted-1, 4-benzodiazepines |
| WO2006035954A1 (en) * | 2004-09-28 | 2006-04-06 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril compound |
| PL1991690T3 (pl) | 2006-03-09 | 2014-07-31 | Centre Nat Rech Scient | Sposób wytwarzania sialilowanych oligosacharydów |
| US20110104282A1 (en) | 2008-04-25 | 2011-05-05 | Karolinska Institutet Innovations Ab | New Therapy of Treatment of the Irritable Bowel Syndrome |
| EP2417144B1 (en) | 2009-04-07 | 2017-08-23 | Glycom A/S | Synthesis of 2'-o-fucosyllactose |
| JP2012532195A (ja) | 2009-07-06 | 2012-12-13 | チルドレンズ ホスピタル メディカル センター | 乳オリゴ糖による炎症の阻害 |
| US8993740B2 (en) | 2010-02-19 | 2015-03-31 | Glycom A/S | Method for preparation of the tetrasaccharide lacto-N-neotetraose (LNnt) containing N-acetyllactosamine |
| BR112012020791A2 (pt) | 2010-02-19 | 2016-05-03 | Glycom As | produção de 6'-o-sialillactose e intermediários |
| US9119869B2 (en) * | 2010-04-29 | 2015-09-01 | Ronald J. Shebuski | Mucin derived polypeptides |
| US9200091B2 (en) * | 2010-07-12 | 2015-12-01 | The Regents Of The University Of California | Bovine milk oligosaccharides |
| KR20140001198A (ko) | 2010-07-16 | 2014-01-06 | 글리콤 에이/에스 | 신규 시알로올리고당 유도체들의 합성 |
| EP2454948A1 (en) | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharide mixture and food product comprising this mixture, especially infant formula |
| MX356184B (es) * | 2010-12-31 | 2018-05-17 | Abbott Lab | Fórmulación pediátrica sintética que comprende un probiótico. |
| NZ611807A (en) * | 2010-12-31 | 2015-02-27 | Abbott Lab | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
| BR112013016929A2 (pt) * | 2010-12-31 | 2019-09-24 | Abbott Lab | oligossacarídeos de leite humano para promover o crescimento de bactérias benéficas |
| BR112013019522A2 (pt) * | 2011-02-04 | 2019-09-24 | Univ California | dissialil lacto-n-tetraose (dslnt) ou as variantes, os isômeros, os análogos e os derivados da mesma para prevenir ou inibir doença do intestino |
| US20140057868A1 (en) | 2011-02-21 | 2014-02-27 | Glycom A/S | Catalytic hydrogenolysis of a composition of a mixture of oligosaccharide precursors and uses thereof |
| CN103443113A (zh) | 2011-03-18 | 2013-12-11 | 格力康公司 | 新型含岩藻糖的糖类衍生物的合成 |
| BR112013029203A2 (pt) | 2011-05-13 | 2016-08-09 | Glycom As | método para a preparação de um ou mais oligossacarídeos de leite humano, e, uso de oligossacarídeos de leite humano |
| EP2712362A4 (en) | 2011-05-13 | 2014-12-24 | Glycom As | MANUFACTURE OF LACTO-N-TETRAOSE |
| BR112013029208A2 (pt) | 2011-05-13 | 2017-02-14 | Glycom As | método para preparar um ou mais oligossarídeos de leite humano ou derivados ou precursores dos mesmos, uso de oligossacarídeos, e, composto |
| US20140235850A1 (en) | 2011-09-30 | 2014-08-21 | Glycom A/S | Synthesis of hmo core structures |
| WO2013091660A1 (en) | 2011-12-23 | 2013-06-27 | Glycom A/S | A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof |
| US20150065702A1 (en) | 2012-03-20 | 2015-03-05 | Glycom A/S | Synthesis of the Trisaccharide 3-O-Fucosyllactose and Intermediates Thereof |
| CN110301646A (zh) * | 2012-03-27 | 2019-10-08 | 雅培制药有限公司 | 用于使用人乳寡糖调节细胞介导的免疫的方法 |
| MX2014012362A (es) * | 2012-04-13 | 2015-05-07 | Trustees Boston College | Composición prebiótica y métodos de uso. |
| JPWO2013161693A1 (ja) * | 2012-04-27 | 2015-12-24 | トライエックス・バイオメディカル株式会社 | 腸内細菌異常増殖による過敏性腸症候群の診断剤及び診断法 |
| US10568896B2 (en) | 2013-11-19 | 2020-02-25 | Abbott Laboratories | Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides |
| HK1231398A1 (zh) * | 2014-04-08 | 2017-12-22 | Abbott Laboratories | 使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法 |
| US11040049B2 (en) | 2014-10-29 | 2021-06-22 | Glycom A/S | Composition comprising HMSs/HMOs and use thereof |
| US20160346303A1 (en) | 2014-10-29 | 2016-12-01 | Glycom A/S | Synthetic composition and method for treating irritable bowel syndrome |
| US11040050B2 (en) | 2014-10-29 | 2021-06-22 | Glycom A/S | Composition comprising HMSs/HMOs and use thereof |
| ES2886951T3 (es) | 2015-09-14 | 2021-12-21 | Glycom As | Composición para su uso en la modulación de la microbiota |
| TWI715424B (zh) * | 2020-01-22 | 2021-01-01 | 長春石油化學股份有限公司 | 電解銅箔、電極及包含其之鋰離子電池 |
-
2015
- 2015-10-29 US US15/034,593 patent/US20160346303A1/en not_active Abandoned
- 2015-10-29 CN CN202211004557.3A patent/CN115364113A/zh active Pending
- 2015-10-29 JP JP2017523330A patent/JP7182872B2/ja not_active Expired - Fee Related
- 2015-10-29 WO PCT/DK2015/050332 patent/WO2016066175A1/en not_active Ceased
- 2015-10-29 CN CN201580058523.4A patent/CN107073021A/zh active Pending
- 2015-10-29 EP EP15854904.8A patent/EP3212197A4/en not_active Withdrawn
-
2018
- 2018-02-14 US US15/897,099 patent/US11026959B2/en not_active Expired - Fee Related
-
2021
- 2021-06-07 US US17/341,039 patent/US11833165B2/en active Active
- 2021-06-23 JP JP2021103785A patent/JP7301093B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2008140167A (ru) | Применение неусвояемых сахаридов для лучшей адаптации младенцев после рождения | |
| Ojetti et al. | The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial | |
| Yasmin et al. | Prebiotics, gut microbiota and metabolic risks: Unveiling the relationship | |
| JP2021152062A (ja) | 過敏性腸症候群の治療のための合成組成物および方法 | |
| RU2013128570A (ru) | Олигосахаридная композиция для лечения острых инфекций дыхательных путей | |
| JP2015523321A5 (cg-RX-API-DMAC7.html) | ||
| RU2008119992A (ru) | Предупреждение заболеваний у детей, рожденных посредством кесарева сечения | |
| RU2018107583A (ru) | Питательные композиции с 2fl и lnnt для применения при индукции кишечной микробиоты, которая похожа на кишечную микробиоту младенцев на грудном вскармливании | |
| JP2021504420A5 (cg-RX-API-DMAC7.html) | ||
| RU2006144870A (ru) | Синергизм галактоолигосахаридов и полифруктозы | |
| RU2005121665A (ru) | Пребиотические композиции | |
| JP2009535419A5 (cg-RX-API-DMAC7.html) | ||
| MX337667B (es) | Combinacion simbiotica para mejorar la microbiota intestinal. | |
| PH12015501309A1 (en) | Human milk oligosaccharides to ameliorate symptoms of stress | |
| RU2013128594A (ru) | Композиция для применения с целью предупреждения и/или лечения состояний кожи и заболеваний кожи | |
| RU2017113997A (ru) | Система детской смеси с адаптивными концентрациями олигосахаридов грудного молока (огм) | |
| CN101801220A (zh) | 含有非活的双歧杆菌和非消化性寡糖的营养物 | |
| CN105283195A (zh) | 用于治疗过敏患者的感染的合生素组合物 | |
| JP2019508486A5 (cg-RX-API-DMAC7.html) | ||
| Licht et al. | Prebiotics for prevention of gut infections | |
| CN101686995A (zh) | Hiv患者肠内菌群的调节 | |
| Kim et al. | Ameliorating effect of 2′-fucosyllactose and 6′-sialyllactose on lipopolysaccharide-induced intestinal inflammation | |
| EP3471562A1 (en) | Synthetic compositions comprising human milk oligosaccharides for use the prevention and treatment of disorders | |
| JP2020529431A5 (cg-RX-API-DMAC7.html) | ||
| RU2018127650A (ru) | Ферментированная молочная смесь с неперевариваемыми олигосахаридами |